Live from the NIH registry
Studies recruiting near Wichita right now
Top 25 of 160 recruiting studies, sorted by proximity — each links to its official registry page
Immunogenicity, Safety, and Tolerability of rF1V-1018 Vaccine in Adults 18 to 55 Years of Age
Prevention of Pneumonic Plague Resulting From Aerosol Exposure to Yersinia Pestis
Phase 2
Interventional 148 participants sought
AMR- El Dorado — El Dorado, Kansas (27.8 mi)
· Sponsor: Dynavax Technologies Corporation
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
Type 2 Diabetes, Cortisol Excess
Phase 2
Interventional 1,500 participants sought
Alliance for Multispecialty Research - Wichita East — Wichita, Kansas (0.4 mi)
· Sponsor: Sparrow Pharmaceuticals
Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V
Lupus Nephritis
Phase 2
Interventional 240 participants sought
Wichita Community Clcl Onco Program — Wichita, Kansas (0.4 mi)
· Sponsor: Novartis Pharmaceuticals
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
Non-small Cell Lung Cancer
Phase 3
Interventional 1,000 participants sought
Cancer Center of Kansas — Wichita, Kansas (0.4 mi)
· Sponsor: Bristol-Myers Squibb
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Metabolic Dysfunction-Associated Steatotic Liver Disease
Phase 3
Interventional 4,500 participants sought
AMR Clinical — El Dorado, Kansas (27.8 mi)
· Sponsor: Eli Lilly and Company
Endurant Stent Graft System vs Excluder Endoprothesis: ADVANCE Trial
Abdominal Aortic Aneurysm, Abdominal Aortic Aneurysm >= 5.5 Centimeters in Male (Disorder)
N/A
Interventional 600 participants sought
Ascension Via Christi Saint Francis — Wichita, Kansas (0.4 mi)
· Sponsor: Medtronic Cardiovascular
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
Colorectal Neoplasms
Phase 3
Interventional 1,000 participants sought
Cancer Center of Kansas — Wichita, Kansas (0.4 mi)
· Sponsor: Janssen Research & Development, LLC
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
Newly Diagnosed Multiple Myeloma
Phase 3
Interventional 750 participants sought
Research Site — Wichita, Kansas (0.4 mi)
· Sponsor: AstraZeneca
Global Paradise System US Post Approval Study
Hypertension, Cardiovascular Diseases
N/A
Observational 1,000 participants sought
Ascension via Christi St. Francis — Wichita, Kansas (0.4 mi)
· Sponsor: ReCor Medical, Inc.
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Triple-Negative Breast Cancer
Phase 3
Interventional 1,530 participants sought
Cancer Center of Kansas ( Site 0004) — Wichita, Kansas (0.4 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
Crohn Disease
Phase 2, Phase 3
Interventional 1,092 participants sought
Kansas Gastroenterology, LLC — Wichita, Kansas (0.4 mi)
· Sponsor: Janssen Research & Development, LLC
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
COPD (Chronic Obstructive Pulmonary Disease)
Phase 3
Interventional 5,000 participants sought
Research Site — Wichita, Kansas (0.4 mi)
· Sponsor: AstraZeneca
Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes
Obesity
Phase 3
Interventional 1,200 participants sought
Kailera Clinical Site — Newton, Kansas (24.7 mi)
· Sponsor: Kailera
A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis
Uterine Fibroids, Endometriosis
Phase 3
Interventional 1,000 participants sought
Wichita — Wichita, Kansas (0.4 mi)
· Sponsor: Sumitomo Pharma Switzerland GmbH
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Diabetes Mellitus, Type 2, Hypertension
Phase 3
Interventional 11,800 participants sought
Tekton Research - Wichita — Wichita, Kansas (0.4 mi)
· Sponsor: Boehringer Ingelheim
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
Obesity With Diabetes, Overweight With Diabetes
Phase 3
Interventional 1,156 participants sought
Kailera Clinical Site — Newton, Kansas (24.7 mi)
· Sponsor: Kailera
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
Moderately to Severely Active Crohns Disease
Phase 3
Interventional 600 participants sought
Kansas Gastroenterology, LLC under Clinical Trials Network — Wichita, Kansas (0.4 mi)
· Sponsor: Hoffmann-La Roche
A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
Acute Migraine
Phase 3
Interventional 1,000 participants sought
Heartland Research Associates, LLC - An AMR Company — Wichita, Kansas (0.4 mi)
· Sponsor: Kallyope Inc.
A Study to Identify and Characterize Patients With Type 2 Diabetes Mellitus for Possible Participation in Ongoing or Future Type 2 Diabetes Mellitus Clinical Studies
Type 2 Diabetes
N/A
Observational 2,150 participants sought
Research Site — El Dorado, Kansas (27.8 mi)
· Sponsor: AstraZeneca
Study to Learn More About the Safety and Effectiveness of the Drug VITRAKVI During Routine Use in Patients With TRK Fusion Cancer Which is Locally Advanced or Spread From the Place Where it Started to Other Places in the Body
Locally Advanced or Metastatic Solid Tumor Harboring an NTRK Gene Fusion
N/A
Observational 150 participants sought
Cancer Center of Kansas — Wichita, Kansas (0.4 mi)
· Sponsor: Bayer
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
End Stage Kidney Disease
Phase 2, Phase 3
Interventional 3,110 participants sought
Kansas Nephrology Physicians, PA — Wichita, Kansas (0.4 mi)
· Sponsor: CSL Behring
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
B Acute Lymphoblastic Leukemia
Phase 3
Interventional 303 participants sought
Cancer Center of Kansas-Wichita Medical Arts Tower — Wichita, Kansas (0.4 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Esophagus
Esophageal Stricture
Phase 3
Interventional 198 participants sought
Kansas Gastroenterology, LLC — Wichita, Kansas (0.4 mi)
· Sponsor: GIE Medical
A Study of MACI in Patients Aged 17 to 65 Years With Symptomatic Chondral or Osteochondral Defects of the Ankle
Chondral Defect, Articular Cartilage Defect
Phase 3
Interventional 309 participants sought
Elevate Clinical Research Wichita — Wichita, Kansas (0.4 mi)
· Sponsor: Vericel Corporation
A Study to Learn About How a New Pneumococcal Vaccine Works in Infants.
Pneumococcal Disease
Phase 3
Interventional 3,230 participants sought
Integrity Clinical Network, LLC — Derby, Kansas (10.8 mi)
· Sponsor: Pfizer